ArticleTranslational psychiatry2025
Cannabinoid CB1 receptor in dopaminergic circuit from ventral tegmental area to nucleus accumbens links trait anxiety with reward learning.
Article in Translational psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
The endocannabinoid (eCB) system has risen as a critical modulator linking the environmental challenges to behavioral maladaptation, such as trait anxiety and reward learning impairment. However, the association between trait anxiety and reward learning and how they share molecular mechanism in eCB system is still unknown. Here, we utilized a series of behavioral tests to screen the correlation among the behavioral patterns, especially between trait anxiety and reward learning. The elevated platform stress and open field test (OFT) were employed to classify the mice into the different level of trait anxiety, and ethanol-induced conditioned place preference (CPP) was used to assess the ability of reward learning. Our results indicated that high trait anxiety (HTA) mice exhibited increased reward learning. Intracranial administration of the cannabinoid CB1 receptor (CB1R) antagonist AM-251 or agonist WIN55,212-2 in nucleus accumbens (NAc) showed the different effect on anxiety-like behavior and reward learning. Similarly, CB1R knockout in VTA dopaminergic (VTA
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.